RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer. Compadre AJ, van Biljon LN, Valentine MC, Llop-Guevara A, et al. Clin Cancer Res 2023 Apr 25:CCR-22-3335. doi: 10.1158/1078-0432.CCR-22-3335.

Read + Share

Amedeo Smart

Independent Medical Education

Compadre AJ, van Biljon LN, Valentine MC, Llop-Guevara A, et al. RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer. Clin Cancer Res 2023 Apr 25:CCR-22-3335. doi: 10.1158/1078-0432.CCR-22-3335.
PMID: 37097615